Patents Represented by Attorney Francis X. Murphy
  • Patent number: 3964924
    Abstract: A coating composition for the protection of graphite electrodes comprising a water dispersion of the following ingredients based on total solids: 35 to 65 percent oxide-coated particulate silicon, 15 to 40 percent colloidal silica, 2 to 10 percent powdered carbon and 5 to 20 percent ground glass.
    Type: Grant
    Filed: July 11, 1975
    Date of Patent: June 22, 1976
    Assignee: Pfizer Inc.
    Inventor: Ronald Kurzeja
  • Patent number: 3954862
    Abstract: The catalytic hydrogenation of 6-methylenetetracyclines, or salts of these compounds, in a reaction-inert solvent medium containing a catalytic amount of rhodium metal to which a phosphine and a promoter is added.
    Type: Grant
    Filed: December 3, 1973
    Date of Patent: May 4, 1976
    Assignee: Pfizer Inc.
    Inventor: Thomas A. Morris, Jr.
  • Patent number: 3950390
    Abstract: A new process for the production of citric acid, and intermediates therefor of the formula: ##SPC1##Wherein R' is cyano or CO-R.sup.2, wherein R.sup.2 is lower alkoxy, amino or hydroxy.
    Type: Grant
    Filed: August 26, 1974
    Date of Patent: April 13, 1976
    Assignee: Pfizer Inc.
    Inventor: Hermann Faubl
  • Patent number: 3934027
    Abstract: Amide derivatives of 18.beta.-glycyrrhetinic acid and its 3-alkanoyl derivatives useful as antiulcer agents wherein the amide is derived from an amino acid.
    Type: Grant
    Filed: June 24, 1974
    Date of Patent: January 20, 1976
    Assignee: Pfizer Inc.
    Inventors: Hans-Jurgen E. Hess, Roger P. Nelson
  • Patent number: 3932643
    Abstract: Phenanthridines and phenanthridinones of the formulae ##SPC1##And the pharmaceutically-acceptable acid addition salts thereof wherein X is chloro, bromo, hydroxy, alkoxy having from 1 to 6 carbon atoms, amino, monoalkylamino, dialkylamino wherein each of the alkyl groups has from 1 to 6 carbon atoms, and benzylamino; R is hydrogen, alkyl having from 1 to 6 carbon atoms, --A--NR.sub.1 R.sub.2 wherein each of R.sub.1 and R.sub.2 is alkyl having from 1 to 6 carbon atoms and A is a divalent alkylene radical having from 2 to 6 carbon atoms; and each of Y and Z is hydrogen, and .omega.-dialkylaminoalkoxy wherein the alkyl and alkoxy groups have from 1 to 6 carbon atoms, and from 2 to 6 carbon atoms, respectively; with the proviso that when R is hydrogen or alkyl, each of Y and Z is dialkylaminoalkoxy; useful as antiviral agents and/or interferon inducers and methods for their preparation.
    Type: Grant
    Filed: June 7, 1974
    Date of Patent: January 13, 1976
    Assignee: Pfizer Inc.
    Inventor: George J. Gauthier